Compare stocks

Straumann Holding AG operates in the healthcare sector, focusing on dental and orthodontic solutions. The company specializes in developing and manufacturing dental implants, clear aligners, and digital solutions for dentists and orthodontists. Founded in 1954 and headquartered in Basel, Switzerland, Straumann has expanded its geographic footprint globally with operations in Europe, North America, Latin America, and Asia Pacific. The company's strategic positioning is supported by its strong focus on research and development, which contributes to its innovative product offerings and comprehensive digital dentistry solutions. Straumann's competitive strengths include its robust product portfolio and extensive network of professional training and support services for dental practitioners.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.